The invention of the long awaited solution to mental disorders has finally come to be. The proposed psychiatric diagnosis and treatment device includes a Smartphone that according to Mindstrong Health, will be used in various brain diagnosis projects. To accomplish this plans, a health program start up, by the name, Mindstrong Health, has been introduced to the health sector. Mindstrong Health has, so far, set aside about $14 million with its primary focus being to improve the treatment of neuropsychiatric disorders. To attain this kind of funds, and for its innovative invention, the startup received an enormous financial support from various investors such as; the Forsite Capital, ARCH Ventures Partners, and One Mind Brain Health Impact Fund among others.
The founder and C.E.O of Mindstrong Health Mr. Paul Dagum Saud, in his statement, said that mental disorders had been a rare case to detect in various occasions in a clinical environment. He, therefore, saw the need for such a device in the health industry. He reinforces by saying that, the ailment has no difference with other chronic diseases such as diabetes, and heart diseases, for these reasons, the disease should also be given a high priority by most health facilities. This in return, will contribute to a better outcome of people with mental disorders. The procedure will include the use of a Smartphone to measure brain function. During this process, the patient will have to scroll and type on a phone as the device detects the patterns obtained, and therefore easily displaying the brain functionality information. This process focuses primarily on the patient mood and cognition biomarkers. For instance; it detects the brain processing speed and its memory status. Visit LinkedIn to know more.
Jim Tananbaum is an experienced investor in the health care sector. He participated in the construction and management of various health care companies. To start with, he founded a company by the name GelTex Pharmaceuticals, in the earlier years, right after his graduation from Harvard Medical School. GelTex managed to introduce two new brands of medicine to the health market, and to date, the drugs are trading on a high scale of about $1 billion revenues. Apart from that, he also founded Theravance Inc and Theravance Biopharma, alongside the other two that he also co-founded
Jim Tananbaum is a graduate of different institutions such as; the Harvard Medical School, M.S where he attained an M.D. He also holds B.S.S.E & B.S from Yale University, and lastly, he graduated from Harvard Business School with an M.B.A among others. Besides, Mr. Tananbaum has been on the Harvard’s-MIT HST programs advisory board, and a presidential advisory counsel at Yale University. Visit officialjimtananbaum.com